Priority 2 from the Sight Loss and Vision PSP Cataract
| UNCERTAINTY: Can the return of cloudy or blurred vision after cataract surgery known as posterior capsule opacity (PCO) or secondary cataract be prevented? (JLA PSP Priority 2) | |
|---|---|
| Overall ranking | 2 |
| JLA question ID | 0014b/2 |
| Explanatory note | No relevant systematic reviews identified at the time of the PSP |
| Evidence | None identified |
| Health Research Classification System category | Eye |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | None available |
| Systematic reviews in preparation (at the time of PSP) | None identified |
| Ongoing controlled trials | Effect of topical prednisolone and diclofenac on the morphology of Posterior Capsule Opacification https://www.clinicaltrialsregister.eu/ctr-search/search? query=eudract_number:2004-004263-30 |
| Submitted by | Clinicians |
| Outcomes to be measured | Management and or change of symptoms; adverse effects or complications; acceptability to patients or carers; time to return to work or normal activity; time in hospital and or needing health or social care services; health related quality of life; and costs |
| PSP information | |
|---|---|
| PSP unique ID | 0014b |
| PSP name | Sight Loss and Vision - Cataract |
| Total number of uncertainties identified by this PSP. | 42 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | April and May 2013 |